Optex Systems Holdings, Inc. - Common Stock (OPXS)

Today's MicroMarvel is Optex Systems, an aerospace & defense company that has gained 63.86% since a buy signal on 11/15.

Optex Systems Holdings Inc (NASDAQ: OPXS) has secured a delivery order from the U.S.

Optex Systems Hldgs just reported results for the third quarter of 2024.

By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories.

Optex Systems Hldgs just reported results for the second quarter of 2024.

Even though these are A-rated stocks, institutional and retail investors can easily overlook them, creating real opportunities.

As of Jan. 23, 2024, five stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.

Stocks under $10 can serve as a memorable and potentially profitable addition to your Christmas stocking while diversifying your holdings.

These seven up-and-coming penny stocks represent strong growth opportunities, and all sport reasonable valuations.

Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.

While the hot flavors of the week are nice, astute investors may find more success with underappreciated value stocks to buy.

The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!

Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.

Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) rose 38.9% to $5.82 in pre-market trading. ThermoGenesis shares jumped around 99% on Wednesday after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.